| HER2 directed antibody-drug-conjugates beyond T-DM1 in breast cancer G Rinnerthaler, SP Gampenrieder, R Greil International journal of molecular sciences 20 (5), 1115, 2019 | 220 | 2019 |
| Duration of adjuvant aromatase-inhibitor therapy in postmenopausal breast cancer M Gnant, F Fitzal, G Rinnerthaler, GG Steger, S Greil-Ressler, M Balic, ... New England Journal of Medicine 385 (5), 395-405, 2021 | 136 | 2021 |
| Neoadjuvant chemotherapy and targeted therapy in breast cancer: past, present, and future SP Gampenrieder, G Rinnerthaler, R Greil Journal of oncology 2013 (1), 732047, 2013 | 119 | 2013 |
| Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry SP Gampenrieder, G Rinnerthaler, C Tinchon, A Petzer, M Balic, S Heibl, ... Breast Cancer Research 23 (1), 112, 2021 | 110 | 2021 |
| Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancer F Huemer, G Rinnerthaler, T Westphal, H Hackl, G Hutarew, ... Oncotarget 9 (23), 16512, 2018 | 88 | 2018 |
| miR-16-5p is a stably-expressed housekeeping microRNA in breast cancer tissues from primary tumors and from metastatic sites G Rinnerthaler, H Hackl, SP Gampenrieder, F Hamacher, C Hufnagl, ... International journal of molecular sciences 17 (2), 156, 2016 | 85 | 2016 |
| Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free … SP Gampenrieder, A Peer, C Weismann, M Meissnitzer, G Rinnerthaler, ... Breast Cancer Research 21, 1-11, 2019 | 76 | 2019 |
| MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors D Schwarzenbacher, C Klec, B Pasculli, S Cerk, B Rinner, M Karbiener, ... Breast Cancer Research 21, 1-15, 2019 | 68 | 2019 |
| Prognostic and predictive factors in advanced head and neck squamous cell carcinoma T Magnes, S Wagner, D Kiem, L Weiss, G Rinnerthaler, R Greil, ... International journal of molecular sciences 22 (9), 4981, 2021 | 66 | 2021 |
| Baseline absolute lymphocyte count and ECOG performance score are associated with survival in advanced non-small cell lung cancer undergoing PD-1/PD-L1 blockade F Huemer, D Lang, T Westphal, SP Gampenrieder, G Hutarew, L Weiss, ... Journal of clinical medicine 8 (7), 1014, 2019 | 60 | 2019 |
| Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones T Melchardt, C Hufnagl, DM Weinstock, N Kopp, D Neureiter, ... Oncotarget 7 (32), 51494, 2016 | 55 | 2016 |
| Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: results from a retrospective matched-pair analysis SP Gampenrieder, F Romeder, C MUß, M Pircher, S Ressler, ... Anticancer research 34 (1), 227-233, 2014 | 50 | 2014 |
| Female gender may predict response to FOLFIRINOX in patients with unresectable pancreatic cancer: a single institution retrospective review F Hohla, G Hopfinger, F Romeder, G Rinnerthaler, A Bezan, S Stättner, ... International journal of oncology 44 (1), 319-326, 2013 | 47 | 2013 |
| Persistence of ctDNA in patients with breast cancer during neoadjuvant treatment is a significant predictor of poor tumor response Q Zhou, SP Gampenrieder, S Frantal, G Rinnerthaler, CF Singer, D Egle, ... Clinical Cancer Research 28 (4), 697-707, 2022 | 46 | 2022 |
| Combination strategies for immune-checkpoint blockade and response prediction by artificial intelligence F Huemer, M Leisch, R Geisberger, T Melchardt, G Rinnerthaler, ... International journal of molecular sciences 21 (8), 2856, 2020 | 46 | 2020 |
| Supervised versus autonomous exercise training in breast cancer patients: A multicenter randomized clinical trial T Westphal, G Rinnerthaler, SP Gampenrieder, J Niebauer, J Thaler, ... Cancer medicine 7 (12), 5962-5972, 2018 | 37 | 2018 |
| Clonal evolution and heterogeneity in metastatic head and neck cancer—An analysis of the Austrian Study Group of Medical Tumour Therapy study group T Melchardt, T Magnes, C Hufnagl, AR Thorner, M Ducar, D Neureiter, ... European Journal of Cancer 93, 69-78, 2018 | 35 | 2018 |
| DNA methylation signatures predicting bevacizumab efficacy in metastatic breast cancer SP Gampenrieder, G Rinnerthaler, H Hackl, W Pulverer, A Weinhaeusel, ... Theranostics 8 (8), 2278, 2018 | 35 | 2018 |
| Cure in metastatic breast cancer T Westphal, SP Gampenrieder, G Rinnerthaler, R Greil memo-Magazine of European Medical Oncology 11, 172-179, 2018 | 31 | 2018 |
| ASCO 2018 highlights: metastatic breast cancer G Rinnerthaler, SP Gampenrieder, R Greil memo-Magazine of European Medical Oncology 11, 276-279, 2018 | 25 | 2018 |
Greil-rProfessor of Medicine, Paracelsus Medical University Salzburg在 salk.at 的电子邮件经过验证
